Streetbeat News

Regulatory

PACS

Edelson Lechtzin LLP is investigating PACS Group Inc. (NASDAQ: PACS) for potential violations of federal securities laws due to allegations of misleading business information. Investors with substantial losses or relevant information are encouraged to contact the firm.

Portfolio Pulse from

November 11, 2024 | 2:15 am

BNO

Oil prices declined in early Asian trade due to concerns over the impact of Trump's tariffs on China's economic growth, which could reduce oil demand.

Portfolio Pulse from

November 11, 2024 | 1:30 am

BEN

Franklin Resources, Inc. is under investigation by Levi & Korsinsky for potential violations of federal securities laws. The investigation follows a Wells Notice received by Ken Leech, co-Chief Investment Officer of its subsidiary Western Asset Management Company.

Portfolio Pulse from

November 10, 2024 | 10:45 pm

OB

SMAR

Halper Sadeh LLC is investigating SMAR and OB for potential violations of federal securities laws and breaches of fiduciary duties to shareholders.

Portfolio Pulse from

November 10, 2024 | 10:30 pm

TSM

TSMC has been ordered by the US Department of Commerce to stop shipments of advanced chips to Chinese companies after a chip was found in a Huawei processor.

Portfolio Pulse from

November 10, 2024 | 7:45 pm

CXSE

In August and September 2024, Japan's policy communication caused a spike in the yen and a drop in equities, while China's stimulus led to a market rally, highlighting the impact of policy on equity returns.

Portfolio Pulse from

November 10, 2024 | 5:45 pm

AYRWF

The U.S. cannabis market has seen a pullback, but potential federal reforms and projected industry growth have renewed interest in marijuana stocks. The industry is expected to grow 14% annually through 2028, reaching over $50 billion.

Portfolio Pulse from

November 10, 2024 | 5:15 pm

TKO

The Schall Law Firm is investigating TKO Group Holdings Inc. for potential breaches of fiduciary duty by its directors and management. Investors with losses are encouraged to join the inquiry into possible securities law violations.

Portfolio Pulse from

November 10, 2024 | 4:15 pm

MYGN

Levi & Korsinsky has initiated an investigation into Myriad Genetics, Inc. for potential federal securities law violations. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test starting January 1, 2025.

Portfolio Pulse from

November 10, 2024 | 4:15 pm